# TPG Inc.: overview

TPG · Nasdaq · CIK 1880661 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tpg.md) · [Financials](/companies/tpg/financials.md) · [Filings](/companies/tpg/filings.md) · [Insiders](/companies/tpg/insiders.md)

Latest reported revenue: [$705.0m](/filings/0001880661-26-000049.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001880661-26-000049).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [525](/filings/0001880661-25-000077.md) | [527 d](/filings/0001880661-26-000011.md) | [543](/filings/0001880661-26-000033.md) | [569](/filings/0001880661-26-000049.md) | [596](/filings/0001880661-25-000077.md) | [715 d](/filings/0001880661-26-000011.md) | [620](/filings/0001880661-26-000033.md) | [705](/filings/0001880661-26-000049.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [1.7%](/filings/0001880661-25-000077.md) | [2.5% d](/filings/0001880661-26-000011.md) | [4.7%](/filings/0001880661-26-000033.md) | [2.6%](/filings/0001880661-26-000049.md) | [11.3%](/filings/0001880661-25-000077.md) | [10.8% d](/filings/0001880661-26-000011.md) | [(0.2%)](/filings/0001880661-26-000033.md) | [13.3%](/filings/0001880661-26-000049.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001880661-25-000077.md) | not reported | [0.00](/filings/0001880661-26-000033.md) | [(0.05)](/filings/0001880661-26-000049.md) | [0.20](/filings/0001880661-25-000077.md) | not reported | [(0.22)](/filings/0001880661-26-000033.md) | [0.39](/filings/0001880661-26-000049.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [978](/filings/0001880661-24-000013.md) | [1,247](/filings/0001880661-25-000014.md) | [1,535](/filings/0001880661-26-000011.md) | [2,087](/filings/0001880661-26-000011.md) | [2,424](/filings/0001880661-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [0.0%](/filings/0001880661-24-000013.md) | [7.4%](/filings/0001880661-25-000014.md) | [5.2%](/filings/0001880661-26-000011.md) | [1.1%](/filings/0001880661-26-000011.md) | [7.6%](/filings/0001880661-26-000011.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001880661-24-000013.md) | [(0.19)](/filings/0001880661-25-000014.md) | [(0.04)](/filings/0001880661-26-000011.md) | [(0.42)](/filings/0001880661-26-000011.md) | [0.45](/filings/0001880661-26-000011.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tpg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $446.8m | 11,019,487 |  | Added +3,041,560 |
| [Temasek Holdings (Private) Ltd](/funds/1021944.md) | 2026-06-30 | $412.1m | 10,163,065 |  | Added +134,958 |
| [DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP](/funds/1854440.md) | 2026-06-30 | $364.9m | 9,000,000 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $323.6m | 7,980,804 |  | Added +163,263 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $317.6m | 7,833,431 |  | Added +1,220,342 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $261.7m | 6,454,321 |  | Added +371,413 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $261.4m | 6,445,372 |  | Added +163,394 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $229.5m | 5,658,694 |  | Added +584,900 |
| [Balyasny Asset Management L.P.](/funds/1218710.md) | 2026-06-30 | $165.1m | 4,072,169 |  | Added +2,725,700 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $126.4m | 3,117,610 |  | Reduced −642,935 |

## Recent filings

[All 526 filings](/companies/tpg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 16:30 ET | [8-K](/filings/0001880661-26-000051.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001880661-26-000051 |
| 2026-08-18 | 18:13 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000818.md) | Ownership report, active investor, amended | 0000947871-26-000818 |
| 2026-08-04 | 16:01 ET | [10-Q](/filings/0001880661-26-000049.md) | Quarterly report, period 2026-06-30 | 0001880661-26-000049 |
| 2026-08-04 | 08:00 ET | [8-K](/filings/0001880661-26-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001880661-26-000046 |
| 2026-06-22 | 09:21 ET | [8-K](/filings/0001880661-26-000040.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001880661-26-000040 |
| 2026-06-05 | 16:07 ET | [8-K](/filings/0001880661-26-000036.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001880661-26-000036 |
| 2026-05-18 | 17:00 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000557.md) | Ownership report, active investor, amended | 0000947871-26-000557 |
| 2026-05-01 | 16:02 ET | [10-Q](/filings/0001880661-26-000033.md) | Quarterly report, period 2026-03-31 | 0001880661-26-000033 |
| 2026-05-01 | 07:00 ET | [8-K](/filings/0001880661-26-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001880661-26-000029 |
| 2026-04-21 | 16:17 ET | [DEF 14A](/filings/0001193125-26-166834.md) | Proxy statement, period 2026-06-03 | 0001193125-26-166834 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001880661-26-000011.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/919070ae-374b-45f5-98a6-20b0fda6b4ea)

## About the filer

- CIK: 1880661
- Tickers: TPG, TPGXL
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 07:01 ET. No prices; not investment advice.